Displaying drugs 76 - 100 of 12626 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Degarelix | 1632.29 C82H103ClN18O16 |  | A GnRH receptor antagonist used in the management of advanced prostate cancer. | Gonadotropin-releasing Hormone Antagonists / Gonadotropin-Releasing Hormone, antagonists & inhibitors |
| Evernimicin | 1631.42 C70H97Cl2NO38 |  | Investigated for use/treatment in bacterial infection. | Anti-Bacterial Agents / Carbohydrates / Glycosides |
| Iotrolan | 1626.242 C37H48I6N6O18 |  | Nonionic, isotonic contrast medium designed for intrathecal use. | Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media |
| Tridecactide | 1623.85 C75H106N20O19S |  | An investigational modified alpha melanocyte stimulating hormone being studied for the treatment of COVID-19. | Experimental Unapproved Treatments for COVID-19 / Melanocyte-Stimulating Hormones |
| Daptomycin | 1620.693 C72H101N17O26 |  | A cyclic lipopeptide antibiotic used to treat complicated skin and skin structure infections by susceptible Gram-positive bacteria and bacteremia due to Staphylococcus aureus. | Anti-Bacterial Agents / Lipopeptide Antibacterial / Lipopeptides / Peptides, Cyclic |
| Bombesin | 1619.87 C71H110N24O18S |  | Bombesin is under investigation in clinical trial NCT01205321 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and... | Amphibian Venoms / Bombesin, antagonists & inhibitors / Neuropeptides / Neurotransmitter Agents / Peptide Hormones |
| Preimplantation factor | 1614.84 C67H115N21O23S |  | Preimplantation factor is under investigation in clinical trial NCT03593460 (Phase II Autoimmune Hepatitis). | Amino Acids, Peptides, and Proteins |
| Lutetium Lu 177 dotatate | 1609.55 C65H87LuN14O19S2 |  | A radiolabeled somatostatin analog used to treat somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors. | Lutetium / Radiopharmaceuticals |
| Lutetium Lu177 Edotreotide | 1595.57 C65H89LuN14O18S2 |  | Not Annotated | Radiopharmaceuticals |
| 4-epi-vancosaminyl derivative of vancomycin | 1595.47 C73H91Cl2N10O26 |  | Not Available | Not Available |
| Cobamamide | 1579.5818 C72H100CoN18O17P |  | An ingredient found in a variety of supplements and vitamins. | Vitamin B Complex |
| Ganirelix | 1570.35 C80H113ClN18O13 |  | A GnRH antagonist used in assisted reproduction in women undergoing controlled ovarian hyperstimulation to control ovulation by inhibiting the premature LH surges. | Anti-Gonadotropin-Releasing Hormones |
| Epofolate | 1569.74 C67H92N16O22S3 |  | Epofolate has been used in trials studying the treatment of Advanced Solid Tumors. Epofolate (BMS-753493) is a folate conjugate of the epothilone analog BMS-748285 that was designed to selectively target... | Antineoplastic Agents |
| SOR-C13 | 1565.841 C72H116N20O19 |  | SOR-C13 is under investigation in clinical trial NCT01578564 (Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel). | Antineoplastic Agents / Calcium Channel Blockers |
| Sucralfate | 1558.67 C12H35Al9O55S8 |  | A gastro-duodenal protective agent used in the treatment of gastric and duodenal ulcers and to prevent duodenal ulcer recurrence. | Aluminum Complex / Anti-Ulcer Agents / Organometallic Compounds / Thioglycosides |
| Murepavadin | 1553.837 C73H112N22O16 |  | Murepavadin is under investigation in clinical trial NCT02110459 (Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment). | Anti-Bacterial Agents |
| Iodixanol | 1550.1819 C35H44I6N6O15 |  | A contrast agent used during coronary angiography, particularly in patients with renal dysfunction. | Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media |
| Ganglioside GM1 | 1546.841 C73H131N3O31 |  | Not Annotated | Not Annotated |
| DT2216 | 1542.36 C77H96ClF3N10O10S4 |  | Not Annotated | Not Annotated |
| Acyline | 1533.24 C80H102ClN15O14 |  | Acyline has been investigated for the prevention and treatment of Hypogonadism and Contraception. | Gonadotropin-Releasing Hormone, antagonists & inhibitors / Hormone Antagonists |
| Idraparinux | 1529.3 C38H64O49S7 |  | Investigated for use/treatment in thrombosis, venous thromboembolism, strokes, heart disease, and atrial fibrillation. | Factor Xa Inhibitors |
| Siagoside | 1528.826 C73H129N3O30 |  | Siagoside (Sygen, AGF 2) has been investigated for the treatment of Parkinson Disease. It is a naturally occurring substance in the nerve cell’s membrane that is thought to play a... | Acidic Glycosphingolipids / Carbohydrates / Gangliosides / Glycoconjugates / Glycolipids / Glycosphingolipids / Lipids / Membrane Lipids / Neuroprotective Agents / Sphingolipids |
| Octylphenoxy polyethoxyethanol | 1527.9007 C74H142O31 |  | Not Available | Antifoaming Agents / Detergents / Excipients / Polyethylene Glycols / Spermatocidal Agents / Surface-Active Agents |
| Linaclotide | 1526.736 C59H79N15O21S6 |  | A guanylate cyclase-C agonist used to treat different types of constipation, such as irritable bowel syndrome-related constipation, idiopathic constipation, and functional constipation. | Guanylate Cyclase-C Agonist / Guanylyl Cyclase C Agonists |
| Ioforminol | 1522.137 C33H40I6N6O15 |  | Ioforminol has been used in trials studying the diagnostic of Cardio Renal Safety in High-risk Elderly Subjects Undergoing a Coronary CATH With or Without PCI. | Iodine Radioisotopes |
Displaying drugs 76 - 100 of 12626 in total